| Firm | Analyst |
|---|---|
|
Baird
|
Vikram Kesavabhotla
|
|
Bank of America
|
Justin Post
|
|
Barclays
|
Steve Valiquette / Ross Sandler
|
|
Cowen
|
Charles Rhyee
|
|
Credit Suisse
|
Jailendra Singh
|
|
Deutsche Bank
|
George Hill / Lee Horowitz
|
|
Evercore ISI
|
Mark Mahaney
|
|
Goldman Sachs
|
Eric Sheridan
|
|
Jefferies
|
Glen Santangelo
|
|
J.P. Morgan
|
Douglas Anmuth
|
|
Morgan Stanley
|
Ricky Goldwasser / Brian Nowak
|
|
Raymond James
|
John Ransom / Aaron Kessler
|
|
RBC
|
Sean Dodge
|
|
Stephens
|
Scott Schoenhaus
|
|
SVB Leerink
|
Stephanie Davis
|
|
UBS
|
Kevin Caliendo
|
GoodRx is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding GoodRx's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of GoodRx or its management. GoodRx does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
